Report interim data from the AWARE-1 breast cancer study
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 5 Mar 2021
- Due
- 30 Jun 2021
- Delivered
- Q2 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Interim data for AWARE-1 breast cancer study: H1 2021”
What we found
Evidence strength A What the grades mean
A later 6-K under a Second Quarter highlights heading reports AWARE-1 data presented at the AACR 2021 meeting, within H1 2021. The excerpt does not give the exact presentation date.
-
A Oncolytics Biotech Inc. 6-K filed 2021-08-06
“Second Quarter and Subsequent Highlights Breast Cancer Program Achieved primary endpoint in AWARE-1 study” ✓ confirmed on the page
-
A Oncolytics Biotech Inc. 6-K filed 2021-08-06
“Data from the twenty HR+/HER2- early-stage breast cancer patients included in AWARE-1’s first two cohorts were presented in an electronic poster at the American Association for Cancer Research (AACR) Annual Meeting 2021” ✓ confirmed on the page
-
A Oncolytics Biotech Inc. 6-K filed 2021-08-06
“Clinical AWARE-1 trial achieves primary endpoint and confirms that pelareorep is an immunotherapeutic agent” ✓ confirmed on the page
Checked 27 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- Interim data for AWARE-1 breast cancer study
- In the company’s control
- Medium
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Oncolytics Biotech Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-ONCY-025230 · Corrections policy